Result of AGM

RNS Number : 2008O
Cambridge Cognition Holdings PLC
08 June 2022
 

Cambridge Cognition Holdings Plc

(" Cambridge Cognition" or the "Company")


Result of AGM

 

Cambridge Cognition, which develops and markets digital solutions to assess brain health, held its Annual General Meeting ("AGM") earlier today at the registered office of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. Resolutions 1 to 6 put to the AGM were duly passed and resolution 7 was not passed.

 

Proxy votes were received in respect of approximately 34% of the Company's issued share capital and the proxy votes received in respect of each resolution were as follows:

 

Resolution

For

 

Against

 

Withheld

1 - To approve the 2021 report and accounts

9,609,585

90.23%

1,040,000

9.77%

133

2 - To reappoint the auditors

10,643,921

99.95%

5,664

0.05%

133

3 - to authorise the directors to set the auditors remuneration

10,649,585

100.00%

0

0.00%

133

4 - to re-elect Steven Powell as a director

10,630,812

99.99%

547

0.01%

18,359

5 - to re-elect Matthew Stork as a director

10,631,159

99.99%

200

0.01%

18,359

6 - authority to allot shares

9,606,038

90.23%

1,040,200

9.77%

3,480

7 - disapplication of pre-emption rights

5,188,039

48.73%

5,458,199

51.27%

3,480

 

 

Enquiries

 

Cambridge Cognition Holdings plc

Matthew Stork, Chief Executive Officer

Stephen Symonds, Chief Financial Officer

www.cambridgecognition.com

Tel: 01223 810 700

 

Panmure Gordon (UK) Limited (NOMAD and Joint Broker)

Freddy Crossley / Emma Earl / Mark Rogers

Rupert Dearden

Tel: 020 7220 0500

(Corporate Advisory)

(Corporate Broking)

Dowgate Capital Limited (Joint Broker)

David Poutney / James Serjeant

Tel: 020 3903 7715

(Corporate Broking)

IFC Advisory Ltd (Financial PR and IR)

Tim Metcalfe / Graham Herring / Zach Cohen

Tel: 020 3934 6630

cog@investor-focus.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBKFBDQBKDBAK
UK 100

Latest directors dealings